Most independent peptide testing data comes from European labs. That works for European buyers, but for Australian users, international testing means shipping schedule 4 substances out of the country. Here is why local testing is the safer and faster path.
The customs problem
Shipping a peptide vial out of Australia is, legally, exporting a Schedule 4 substance. Even small consumer samples can be intercepted, and the paperwork burden falls on you, not the receiving lab. International testing solves the analytical question but creates a regulatory one.
The turnaround problem
International round-trip shipping adds 2-4 weeks on top of lab turnaround. For a vendor batch you want to verify before ordering more, that's already too slow.
The dataset problem
EU testing labs see EU vendors. Their public CoA databases skew toward European supply chains. Australian buyers source from Australian, Chinese, and Vietnamese vendors that rarely appear in those datasets at all.
What domestic AU testing solves
No customs exposure: domestic Australia Post only.
Domestic accountability: Australian legal entity, ACN registered.
When international testing still makes sense
If you're already in Europe, or you need a second independent opinion on a high-value vial, Janoshik remains a strong option. See our Janoshik vs LabDoc comparison for the full breakdown.
Frequently asked questions
Can I send peptides to Janoshik from Australia?
Technically yes, but shipping Schedule 4 substances out of Australia carries customs risk. The personal-importation rules cover incoming, not outgoing.
Is LabDoc the only Australian option?
Yes. Contract labs like Eurofins AU and ALS run peptide assays for industry but don't accept individual consumer samples. LabDoc is the only consumer-facing AU intake.
Does Australian testing produce different results to international testing?
Methods (LC-MS, HPLC) are identical globally. The differences are turnaround, currency, customs risk, and the AU-specific vendor coverage in the published dataset.